Patents by Inventor John T. Hunt

John T. Hunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10535521
    Abstract: A method of forming a semiconductor device package includes: (1) providing an electronic device including an active surface and a contact pad adjacent to the active surface; (2) forming a package body encapsulating portions of the electronic device; and (3) forming a redistribution stack, including: forming a dielectric layer over a front surface of the package body, the dielectric layer defining a first opening exposing at least a portion of the contact pad; and forming a redistribution layer (RDL) over the dielectric layer, the RDL including a first trace, wherein the first trace includes a first portion extending over the dielectric layer along a first longitudinal direction adjacent to the first opening, and a second portion disposed in the first opening and extending between the first portion of the first trace and the exposed portion of the contact pad, wherein the second portion of the first trace has a maximum width along a first transverse direction orthogonal to the first longitudinal direction, and
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: January 14, 2020
    Assignee: ADVANCED SEMICONDUCTOR ENGINEERING, INC.
    Inventors: John Richard Hunt, William T. Chen, Chih-Pin Hung, Chen-Chao Wang
  • Patent number: 10515806
    Abstract: A semiconductor device package includes: (1) an electronic device including an active surface and a contact pad adjacent to the active surface; and (2) a redistribution stack including a dielectric layer disposed over the active surface and defining a first opening exposing at least a portion of the contact pad; and a redistribution layer (RDL) disposed over the dielectric layer and including a first trace, wherein the first trace includes a first portion extending over the dielectric layer along a first longitudinal direction adjacent to the first opening, and a second portion disposed in the first opening and extending between the first portion of the first trace and the exposed portion of the contact pad, wherein the second portion of the first trace has a maximum width along a first transverse direction orthogonal to the first longitudinal direction, and the maximum width of the second portion of the first trace is no greater than 3 times of a width of the first portion of the first trace, wherein the sec
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: December 24, 2019
    Assignee: ADVANCED SEMICONDUCTOR ENGINEERING, INC.
    Inventors: John Richard Hunt, William T. Chen, Chih-Pin Hung, Chen-Chao Wang
  • Publication number: 20190206684
    Abstract: A method of forming a semiconductor device package includes: (1) providing an electronic device including an active surface and a contact pad adjacent to the active surface; (2) forming a package body encapsulating portions of the electronic device; and (3) forming a redistribution stack, including: forming a dielectric layer over a front surface of the package body, the dielectric layer defining a first opening exposing at least a portion of the contact pad; and forming a redistribution layer (RDL) over the dielectric layer, the RDL including a first trace, wherein the first trace includes a first portion extending over the dielectric layer along a first longitudinal direction adjacent to the first opening, and a second portion disposed in the first opening and extending between the first portion of the first trace and the exposed portion of the contact pad, wherein the second portion of the first trace has a maximum width along a first transverse direction orthogonal to the first longitudinal direction, and
    Type: Application
    Filed: March 8, 2019
    Publication date: July 4, 2019
    Applicant: Advanced Semiconductor Engineering, Inc.
    Inventors: John Richard HUNT, William T. Chen, Chih-Pin HUNG, Chen-Chao WANG
  • Publication number: 20190206683
    Abstract: A semiconductor device package includes: (1) an electronic device including an active surface and a contact pad adjacent to the active surface; and (2) a redistribution stack including a dielectric layer disposed over the active surface and defining a first opening exposing at least a portion of the contact pad; and a redistribution layer (RDL) disposed over the dielectric layer and including a first trace, wherein the first trace includes a first portion extending over the dielectric layer along a first longitudinal direction adjacent to the first opening, and a second portion disposed in the first opening and extending between the first portion of the first trace and the exposed portion of the contact pad, wherein the second portion of the first trace has a maximum width along a first transverse direction orthogonal to the first longitudinal direction, and the maximum width of the second portion of the first trace is no greater than 3 times of a width of the first portion of the first trace, wherein the sec
    Type: Application
    Filed: March 8, 2019
    Publication date: July 4, 2019
    Applicant: Advanced Semiconductor Engineering, Inc.
    Inventors: John Richard HUNT, William T. Chen, Chih-Pin HUNG, Chen-Chao WANG
  • Publication number: 20190183399
    Abstract: A computer-implemented method includes: receiving, by a computing device, information identifying a user's activity; determining, by the computing device, the user's tasks based on the information identifying the user's activity; determining, by the computing device, the user's context switches based on the user's tasks; receiving, by the computing device, biometrics data associated with the user via an application programming interface (API); determining, by the computing device, the user's stress levels at various times based on the biometrics data; storing, by the computing device, information linking the user's stress level with the user's context switches; and outputting, by the computing device, the information linking the user's stress level with the user's context switches.
    Type: Application
    Filed: February 25, 2019
    Publication date: June 20, 2019
    Inventors: John V. Delaney, Sean T. Fornash, Anthony M. Hunt, Maeve O'Reilly, Clea A. Zolotow
  • Patent number: 7244733
    Abstract: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1, PDGFR, HER-1, HER-2, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: July 17, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: John T. Hunt, Rajeev S. Bhide, Robert Michael Borzilleri, Ligang Qian
  • Patent number: 7173031
    Abstract: In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
    Type: Grant
    Filed: June 24, 2005
    Date of Patent: February 6, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Robert M. Borzilleri, Zhong Chen, John T. Hunt, Tram Huynh, Michael A. Poss, Gretchen M. Schroeder, Wayne Vaccaro, Tai W. Wong, Xiao-Tao Chen, Kyoung S. Kim
  • Patent number: 7112675
    Abstract: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1, PDGFR, HER-1, HER-2, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
    Type: Grant
    Filed: July 27, 2005
    Date of Patent: September 26, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: John T. Hunt, Rajeev S. Bhide, Robert Michael Borzilleri, Ligang Qian
  • Publication number: 20060004006
    Abstract: In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
    Type: Application
    Filed: June 24, 2005
    Publication date: January 5, 2006
    Inventors: Robert M. Borzilleri, Zhong Chen, John T. Hunt, Tram Huynh, Michael A. Poss, Gretchen M. Schroeder, Wayne Vaccaro, Tai W. Wong, Xiao-Tao Chen, Kyoung KIm
  • Patent number: 6982265
    Abstract: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1, PDGFR, HER-1, HER-2, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
    Type: Grant
    Filed: May 18, 2000
    Date of Patent: January 3, 2006
    Assignee: Bristol Myers Squibb Company
    Inventors: John T. Hunt, Rajeev S. Bhide, Robert Michael Borzilleri, Ligang Qian
  • Patent number: 6900208
    Abstract: Disclosed are pyrrolopyridazine compounds of the formula, wherein the substituents are defined herein, methods of preparing such compounds, and their use for the treatment of proliferative, inflammatory, and other disorders.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: May 31, 2005
    Assignee: Bristol Myers Squibb Company
    Inventors: Mark Salvati, Stephanie A. Barbosa, Zhong Chen, John T. Hunt
  • Publication number: 20040063712
    Abstract: Disclosed are pyrrolopyridazine compounds, methods of preparing such compounds, and their use for the treatment of proliferative, inflammatory, and other disorders.
    Type: Application
    Filed: March 25, 2003
    Publication date: April 1, 2004
    Inventors: Mark Salvati, Stephanie A. Barbosa, Zhong Chen, John T. Hunt
  • Patent number: 6673824
    Abstract: Compounds of the formula inhibit the activity of endothelin. The symbols are defined as follows: R1, R2 and R3 are each independently (a) hydrogen, except that R1 is other than hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted with Z1, Z2 and Z3; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) —C(O)H or —C(O)R6; (h) —CO2H or —CO2R6; (i) —SH, —S(O)nR6, —S(O)m—OH, —S(O)m—OR6, —O—S(O)m—R6, —O—S(O)mOH or —O—S(O)m—OR6; (j) —Z4—NR7R8; or (k) —Z4—N(R11)—Z5—NR9R10; and the remaining symbols are as defined in the specification.
    Type: Grant
    Filed: April 19, 2000
    Date of Patent: January 6, 2004
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Natesan Murugesan, John T. Hunt, Philip D. Stein
  • Patent number: 6602883
    Abstract: Disclosed are quinoline and benzazepine derivatives that inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogenic protein Ras. Thus, the compounds are useful as anti-cancer agents. The compounds are also useful in the treatment of diseases other than cancer.
    Type: Grant
    Filed: May 5, 2000
    Date of Patent: August 5, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Rajeev S. Bhide, Charles Z. Ding, John T. Hunt, Soong-Hoon Kim, Katerina Leftheris
  • Patent number: 6521759
    Abstract: The present invention describes compounds of formula I: and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, m and n are as defined in the specification. The compounds of formula I are protein kinase inhibitors and are useful in the treatment of proliferative diseases, for example, cancer, inflammation and arthritis. They may also be useful in the treatment of Alzheimer's disease, chemotherapy-induced alopecia, and cardiovascular disease.
    Type: Grant
    Filed: April 20, 2001
    Date of Patent: February 18, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kyoung S. Kim, S. David Kimball, Zhen-wei Cai, David B. Rawlins, Raj N. Misra, Michael A. Poss, Kevin R. Webster, John T. Hunt, Wen-Ching Han
  • Patent number: 6458783
    Abstract: Inhibition of farnesyl transferase, which is an enzyme involved in ras oncogene expression, is effected by compounds of the formulas their enantiomers, diastereomers, and pharmaceutically acceptable salts, prodrugs and solvates thereof.
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: October 1, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Charles Z. Ding, John T. Hunt, Katerina Leftheris, Rajeev S. Bhide
  • Publication number: 20020137778
    Abstract: The present invention describes compounds of formula I: 1
    Type: Application
    Filed: April 20, 2001
    Publication date: September 26, 2002
    Inventors: Kyoung S. Kim, S. David Kimball, Zhen-Wei Cai, David B. Rawlins, Raj N. Misra, Michael A. Poss, Kevin R. Webster, John T. Hunt, Wen-Ching Han
  • Patent number: 6455523
    Abstract: Inhibition of farnesyl transferase, which is an enzyme involved in ras ocogene expression, is effected by compounds of the formulas their enantiomers, diastereomers, and pharmaceutically acceptable salts, prodrugs and solvates thereof inhibit farnesyl protein transferase which is an enzyme involved in ras oncogene expression.
    Type: Grant
    Filed: August 13, 1999
    Date of Patent: September 24, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Charles Z. Ding, Soong-Hoon Kim, John T. Hunt, Toomas Mitt, Rajeev Bhide, Katerina Leftheris
  • Patent number: 6387926
    Abstract: Disclosed are quinoline and benzazepine derivatives that inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogenic protein Ras. Thus, the compounds are useful as anti-cancer agents. The compounds are also useful in the treatment of diseases other than cancer.
    Type: Grant
    Filed: May 29, 1998
    Date of Patent: May 14, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Rajeev S. Bhide, Charles Z. Ding, John T. Hunt, Soong-Hoon Kim, Katerina Leftheris
  • Patent number: D851249
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: June 11, 2019
    Assignee: Ethicon LLC
    Inventors: William D. Fox, Gregory J. Bakos, Jonathan T. Batross, John V. Hunt